CME Group (NASDAQ:CME) Stock Acquired Rep. Carol D. Miller

Representative Carol D. Miller (R-West Virginia) recently bought shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on April 11th, the Representative disclosed that they had bought between $1,001 and $15,000 in CME Group stock on March 10th. The trade occurred in the Representative’s “MATT MILLER INVESTMENT MANAGEMENT ACCOUNT” account.

Representative Carol D. Miller also recently made the following trade(s):

  • Purchased $1,001 – $15,000 in shares of Aflac (NYSE:AFL) on 3/10/2025.
  • Purchased $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 3/10/2025.
  • Purchased $1,001 – $15,000 in shares of Gilead Sciences (NASDAQ:GILD) on 3/10/2025.
  • Sold $1,001 – $15,000 in shares of Pfizer (NYSE:PFE) on 3/10/2025.
  • Purchased $1,001 – $15,000 in shares of Lockheed Martin (NYSE:LMT) on 3/10/2025.
  • Purchased $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 3/10/2025.
  • Purchased $1,001 – $15,000 in shares of Honeywell International (NASDAQ:HON) on 3/10/2025.
  • Sold $1,001 – $15,000 in shares of U.S. Bancorp (NYSE:USB) on 3/10/2025.
  • Sold $1,001 – $15,000 in shares of Target (NYSE:TGT) on 3/10/2025.
  • Purchased $1,001 – $15,000 in shares of American Water Works (NYSE:AWK) on 3/10/2025.

CME Group Trading Down 0.3 %

Shares of NASDAQ:CME opened at $262.87 on Wednesday. The company has a market capitalization of $94.73 billion, a PE ratio of 27.18, a P/E/G ratio of 6.76 and a beta of 0.43. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $273.42. The business’s fifty day simple moving average is $256.03 and its 200-day simple moving average is $239.72.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a $1.25 dividend. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.90%. CME Group’s payout ratio is 51.71%.

Hedge Funds Weigh In On CME Group

Several institutional investors and hedge funds have recently modified their holdings of CME. Lake Street Advisors Group LLC lifted its holdings in CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock valued at $2,949,000 after acquiring an additional 6,453 shares during the period. Meyer Handelman Co. purchased a new stake in CME Group during the fourth quarter worth $6,144,000. Unified Investment Management acquired a new stake in CME Group during the fourth quarter valued at $503,000. Spire Wealth Management raised its position in shares of CME Group by 37.4% in the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock worth $307,000 after acquiring an additional 359 shares during the period. Finally, AEGON ASSET MANAGEMENT UK Plc boosted its stake in shares of CME Group by 19.3% during the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after acquiring an additional 52,862 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CME. Oppenheimer raised their target price on shares of CME Group from $269.00 to $279.00 and gave the company an “outperform” rating in a research note on Friday, April 11th. Bank of America boosted their target price on CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a research note on Wednesday, April 2nd. Morgan Stanley upgraded CME Group from an “equal weight” rating to an “overweight” rating and set a $301.00 price target for the company in a research note on Tuesday, April 8th. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $269.00 price objective on shares of CME Group in a research report on Thursday, April 3rd. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $247.47.

Check Out Our Latest Report on CME

Insider Activity

In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the transaction, the chief operating officer now owns 8,036 shares of the company’s stock, valued at $2,063,885.88. This represents a 15.73 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Howard J. Siegel sold 10,000 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now directly owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. This trade represents a 31.37 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock worth $6,871,496 in the last ninety days. Company insiders own 0.30% of the company’s stock.

About Representative Miller

Carol Miller (Republican Party) is a member of the U.S. House, representing West Virginia’s 1st Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

Miller (Republican Party) ran for re-election to the U.S. House to represent West Virginia’s 1st Congressional District. She won in the general election on November 5, 2024.

West Virginia’s 3rd Congressional District race was identified as a 2018 battleground that might have affected partisan control of the U.S. House in the 116th Congress. Incumbent Evan Jenkins (R) did not seek re-election in 2018, leaving the seat open. In the campaign, Miller emphasized her endorsement by President Donald Trump (R). Lara Trump, Senior Advisor to Donald J. Trump for President, Inc., said, “Carol is pro-coal, pro-Second Amendment, and pro-Trump through and through, and is prepared to tackle the opioid epidemic that’s affected countless West Virginians.” Miller also supported the construction of a wall on the southern U.S. border and the Tax Cuts and Jobs Act (TCJA).

Miller is a former Republican member of the West Virginia House of Delegates, representing District 16 from 2006 to 2018.

Miller has also worked in real estate and owns a bison farm.

Carol Miller was born in Columbus, Ohio. Miller graduated from Bexley High School in 1968. She earned a B.S. from Columbia College in 1972. Her career experience includes owning and operating Swann Ridge Bison Farm and working as a real estate manager.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.